Multiple biomarkers such as C-reactive protein, von Willebrand factor and NT-pro-BNP are used to predict all cause mortality in patients with CAV. Elevated levels of each of these biomarkers signify increased risk of developing CAV. Further research is warranted to help identify the role of biomarkers in diagnosing and predicting CAV.
Cardiac allograft vasculopathy laboratory findings
Sarcoidosis laboratory findings
Cardiac allograft vasculopathy intravascular ultrasound
Cardiac allograft vasculopathy screening
Cardiac allograft vasculopathy optical coherence tomography
Graft-versus-host disease laboratory findings
Heart transplantation classification
Cardiac allograft vasculopathy coronary angiography